David Yang
David is a member of the investment team, where he focuses on the Bio-IT and healthcare space.
Prior to joining 8VC, David was a research associate at the Broad Institute, where he developed new methods for viral diagnostics and sequencing that were published in Nature and Nature Biotech. Previously, David built proactive recommendation engines as a machine learning engineer at Facebook Reality Labs, and worked on deep learning models for protein design at Harvard Medical School.
David graduated magna cum laude from Harvard University, where he studied Computer Science and Biology. Originally from Seattle, Washington, David spent several years living in Vancouver, Canada and Seoul, South Korea.
What’s a Rich Text element?
The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.
Static and dynamic content editing
A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!
How to customize formatting for each rich text
Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

Announcing Our Investment in Photys Therapeutics
We’re pleased to announce 8VC’s participation in the $75 million Series A for Photys Therapeutics, led by MPM Capital and joined by Omega Funds, Longwood, Arkin Bio, Mass General Brigham Ventures, MRL Ventures Fund, Eli Lilly and Company, and Heritage Medical Systems.

Announcing Our Investment in Photys Therapeutics
We’re pleased to announce 8VC’s participation in the $75 million Series A for Photys Therapeutics, led by MPM Capital and joined by Omega Funds, Longwood, Arkin Bio, Mass General Brigham Ventures, MRL Ventures Fund, Eli Lilly and Company, and Heritage Medical Systems.
A Look Back at the Inaugural 8VC Bio-IT Fellowship
At 8VC, we are dedicated to developing partnerships with strong founders. We are now recruiting for the next class of 8VC Bio-IT Fellows — if you are a graduate student with an entrepreneurial interest, please apply here. You can find more information through this flyer.
A Look Back at the Inaugural 8VC Bio-IT Fellowship
At 8VC, we are dedicated to developing partnerships with strong founders. We are now recruiting for the next class of 8VC Bio-IT Fellows — if you are a graduate student with an entrepreneurial interest, please apply here. You can find more information through this flyer.